Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

HIV drug may work as a prophylaxis

  • Comment
An HIV drug should be tested to see if it would act as an effective prophylactic for people who are HIV negative but are at high risk of contracting the infection, according to a group of experts.

An HIVdrug should be tested to see if it would act as aneffective prophylactic for people who are HIV negative but are at high risk of contracting the infection, according to a group of experts.

After reviewing the possible candidates that could act as pre-exposure prophylaxis known as PREP the Dutch team found thatlamivudine (3TC) would work the best against the immunodeficiency virus.

The authors say: '3TC would make an interesting pre-exposure prophylactic drug given its relative safety, ease of use, mode of action and pharmacology, antiviral profile, and cost-effectiveness.?

However they are unsure if the drug would be most effective as monotherapy or in combination and war that it may be necessary to monitor the drug?s impact on chronic hepatitis B infection due to problems with resistant strains.

Public Library of Science Medicine(2006) 3:e454

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.